Humira can now be used in children from 4 years old with severe chronic plaque psoriasis who are inappropriate for, or have not responded sufficiently to topical therapies and phototherapies. The recommended dose is based on weight and administered subcutaneously weekly for the first two weeks then every other week.
Click to search or browse MIMS
The most up-to-date drug information at your fingertips.
- Get the prescribing support you need.
- Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Access the full drug database and quick-reference tables on the go